James A. Geraghty
James Geraghty is Senior Vice President and an Officer of Genzyme Corporation. He was President of Genzyme Europe from 1998-2002, and in 2004 became General Manager of Genzyme’s cardiovascular business. He serves as a Director of GTC Biotherapeutics (formerly Genzyme Transgenics Corporation), where he was Chairman from 1998 to 2001, and President and C.E.O. from its founding in 1993. He is also a member of the boards of Myosix SA, and Genetix Pharmaceuticals, Inc. Mr. Geraghty also oversees Genzyme’s Humanitarian Assistance for Neglected Diseases program, under which Genzyme helps develop innovative therapeutic programs on a non-commercial basis. He has structured Genzyme’s partnerships with The Broad Institute and MMV, with DNDi, with Brazil’s Oswaldo Cruz Institute, and with India’s ICGEB. He served as Co-Chair of the executive committee for BIO 2007 and as an Advisory Board member of the Partnering for Global Health Forum, and of BIO-India. A graduate of the Yale Law School, he has published articles in the Yale Law Journal, Health Affairs, and other publications. He holds a masters degree from the University of Pennsylvania and a bachelor’s degree from Georgetown University.